105 related articles for article (PubMed ID: 7806256)
1. FACS analysis of peritoneal lymphocytes in ovarian cancer and control patients.
Reijnhart RM; Bieber MM; Teng NN
Immunobiology; 1994 Aug; 191(1):1-8. PubMed ID: 7806256
[TBL] [Abstract][Full Text] [Related]
2. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells.
Loercher AE; Nash MA; Kavanagh JJ; Platsoucas CD; Freedman RS
J Immunol; 1999 Dec; 163(11):6251-60. PubMed ID: 10570318
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer.
Berek JS; Bast RC; Lichtenstein A; Hacker NF; Spina CA; Lagasse LD; Knapp RC; Zighelboim J
Obstet Gynecol; 1984 Nov; 64(5):708-14. PubMed ID: 6493663
[TBL] [Abstract][Full Text] [Related]
4. Correlation between soluble Fas level and apoptosis of T cells in ovarian carcinoma.
Ma Y; Ye F; Lv W; Cheng Q; Chen H; Xie X
Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):204-11. PubMed ID: 17826886
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the intracellular expression of interleukin 17 in patients with ovarian cancer].
Rogala E; Nowicka A; Bednarek W; Barczyński B; Wertel I; Zakrzewski M; Kotarski J
Ginekol Pol; 2012 Jun; 83(6):424-8. PubMed ID: 22880461
[TBL] [Abstract][Full Text] [Related]
6. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
[TBL] [Abstract][Full Text] [Related]
7. T lymphocytes and cytokine production in ascitic fluid of ovarian malignancies.
Chen CK; Wu MY; Chao KH; Ho HN; Sheu BC; Huang SC
J Formos Med Assoc; 1999 Jan; 98(1):24-30. PubMed ID: 10063270
[TBL] [Abstract][Full Text] [Related]
8. Myeloid and lymphoid dendritic cells in the peritoneal fluid of women with ovarian cancer.
Wertel F; Polak G; Roliński J; Barczyński B; Kotarski J
Adv Med Sci; 2006; 51():174-7. PubMed ID: 17357302
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte subpopulations in malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study.
Guzman J; Hilgarth M; Bross KJ; Wiehle U; Ross A; Kresin V; Costabel U
Acta Cytol; 1988; 32(6):811-5. PubMed ID: 2974226
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
11. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.
Petersen J
Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810
[TBL] [Abstract][Full Text] [Related]
12. T lymphocyte-enriched murine peritoneal exudate cells. I. A reliable assay for antigen-induced T lymphocyte proliferation.
Schwartz RH; Jackson L; Paul WE
J Immunol; 1975 Nov; 115(5):1330-8. PubMed ID: 51890
[TBL] [Abstract][Full Text] [Related]
13. [Lymphocytic subpopulations in malignant ascites of ovarian origin. Flow cytometric analysis].
De Leonardis A; Casamassima A; Chiuri E; Addabbo L; De Frenza N; Falco G
Minerva Ginecol; 1993 Jun; 45(6):291-300. PubMed ID: 8355884
[TBL] [Abstract][Full Text] [Related]
14. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
[TBL] [Abstract][Full Text] [Related]
15. Targeting human T-lymphocytes with bispecific antibodies to react against human ovarian carcinoma cells growing in nu/nu mice.
Garrido MA; Valdayo MJ; Winkler DF; Titus JA; Hecht TT; Perez P; Segal DM; Wunderlich JR
Cancer Res; 1990 Jul; 50(14):4227-32. PubMed ID: 2142014
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell subsets in the peritoneal fluid and peripheral blood of women suffering from ovarian cancer.
Wertel I; Polak G; Bednarek W; Barczyński B; Roliński J; Kotarski J
Cytometry B Clin Cytom; 2008 Jul; 74(4):251-8. PubMed ID: 18302193
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte activation by recombinant interleukin-2 in ovarian cancer patients.
Boyer PJ; Berek JS; Zighelboim J
Obstet Gynecol; 1989 May; 73(5 Pt 1):793-7. PubMed ID: 2784847
[TBL] [Abstract][Full Text] [Related]
18. T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors.
Smith KG; Austyn JM; Hariri G; Beverley PC; Morris PJ
Eur J Immunol; 1986 May; 16(5):478-86. PubMed ID: 2938973
[TBL] [Abstract][Full Text] [Related]
19. Prospective comparison of blood and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients.
Lewis SL; Bonner PN; Cooper CL; Holmes CJ
J Clin Lab Immunol; 1992 Jan; 37(1):3-19. PubMed ID: 1339234
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytes isolated from the peritoneal fluid of women with advanced ovarian carcinoma differ significantly from autologous peripheral blood lymphocytes.
Melioli G; Ferrari I; Casartelli G; Ragni N
Gynecol Oncol; 1993 Mar; 48(3):301-7. PubMed ID: 8462898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
